Real-World Outcomes with Subcutaneous Immunoglobulin 16.5% in the Treatment of Primary Immunodeficiency

Presented at IgNS 2023

Authors:
Lucinda J. Van Anglen, PharmD
Jeffrey W. Langford, MD, AE-C
Richard F. Herrscher, MD, FACAAI
Precious A. Anyanwu, PharmD, PhD